Allelic exclusion is a process in which a cell uses only one of its two copies of a gene, even though it inherited one copy from each parent. It is best known in the immune system, where each B cell produces only one type of antibody and each T cell displays only one type of receptor. This “one cell, one specificity” rule is one of the most evolutionarily conserved features of adaptive immunity, and it has important consequences for how the body fights infections and avoids attacking itself.
Why Cells Need to Pick One Allele
You carry two copies (alleles) of most genes, one from each parent. For many genes, both copies are active at the same time, and that works fine. But in the immune system, expressing both alleles of an antibody gene would mean a single B cell could produce two different antibodies with two different targets. That creates a problem: the immune system screens developing immune cells to weed out any that react to the body’s own tissues. If a cell carries two receptors and only one of them is tested or detectable during screening, the other might slip through unchecked.
Research in transgenic mouse models has shown exactly this danger. T cells expressing two different receptors can escape the normal quality-control process, even when one of those receptors targets a protein found throughout the body. In one study, T cells with a second, low-level autospecific receptor evaded screening in the thymus, then later attacked insulin-producing cells in the pancreas, causing autoimmune diabetes. The low expression of the rogue receptor was enough to dodge tolerance checks but still sufficient to trigger disease once the cells encountered the right tissue.
Allelic exclusion prevents this scenario by ensuring each immune cell commits to a single antibody or receptor. That commitment makes quality control reliable: if the one receptor a cell expresses passes screening, the cell is safe to release into the body.
How It Works in B Cells
B cells assemble their antibody genes from scattered DNA segments in a process called V(D)J recombination. Because this assembly is essentially random, each cell ends up with a unique antibody. But the cell has two copies of the antibody heavy chain gene and two copies of the light chain gene, so it needs a way to use only one of each.
The mechanism is not a simple on/off silencing of one allele. Both alleles are actually transcribed. The difference is that only one allele gets physically rearranged into a functional gene. The other allele stays in its original, unassembled state, which means it cannot produce a working antibody chain. The result: one functional allele per cell, one antibody specificity per cell.
This makes allelic exclusion in antibody genes fundamentally different from other forms of single-allele expression (like X-chromosome inactivation), where one copy is silenced entirely. In B cells, both copies are “on” at the transcription level, but only one has been cut and reassembled into something that actually works.
The Epigenetic Setup
Before rearrangement begins, the cell uses chemical tags on its DNA and the proteins that package it to mark which allele will be chosen. In developing B cells, one allele replicates its DNA earlier in the cell cycle and moves to an active, open region of the nucleus. The other allele replicates later and is physically relocated to a tightly packed, inactive zone near the center of the chromosome cluster.
The early-replicating allele picks up activating chemical marks on its histone proteins, the spools around which DNA is wound. One mark in particular acts as a landing pad for the recombination machinery, the protein complex that cuts and rejoins the DNA segments. This protein contains a specialized domain that specifically recognizes and docks onto that histone mark, so it binds to only one allele. Studies confirm that this binding is monoallelic: the recombination machinery sits on the marked allele while the other allele remains untouched in its compacted state.
The final step before rearrangement is the removal of methyl groups from the chosen allele’s DNA. After rearrangement, the reassembled allele stays undermethylated, while the untouched allele remains heavily methylated. Even in engineered mice where both alleles carry a pre-assembled, functional antibody gene, mature B cells still methylate one copy and demethylate the other, maintaining the one-allele pattern.
T Cells Use a Feedback Signal
T cells face a similar challenge with their receptor genes. The T cell receptor beta chain gene undergoes allelic exclusion through a feedback loop. Once a developing T cell successfully assembles one beta chain and pairs it with a temporary partner to form a pre-receptor complex, that complex sends a signal through specific signaling proteins inside the cell. This signal shuts down further rearrangement at the second allele.
The signaling pathway that enforces this shutdown appears to be distinct from the pathways the pre-receptor uses for other developmental steps like cell survival and proliferation. In other words, the cell has a dedicated mechanism just for stopping rearrangement, separate from the signals that tell it to keep growing.
Notably, T cell receptor alpha chain genes do not follow strict allelic exclusion. Both alpha alleles can rearrange, meaning some T cells end up with two different alpha chains and therefore two receptor specificities. This “allelic inclusion” at the alpha locus is the loophole that, as described above, can sometimes allow self-reactive receptors to slip past immune screening.
Beyond the Immune System
Allelic exclusion is not limited to immune cells. The most striking non-immune example involves the sense of smell. Humans have hundreds of odorant receptor genes, and each sensory neuron in the nose expresses just one allele of one gene out of the entire family. This means each neuron detects a very specific set of odor molecules, and the brain can map which neurons are firing to identify what you’re smelling.
The mechanism in olfactory neurons couples a slow, chromatin-based activation process with a fast negative-feedback signal. Once one receptor gene is successfully activated, the feedback signal prevents any other receptor gene from turning on. The selection process involves interactions between chromosomes and large-scale reorganization of how DNA is arranged inside the nucleus, coordinating enhancer elements spread across multiple chromosomes to ensure only one gene “wins.”
Other genes that show single-allele expression include certain immune signaling molecules, natural killer cell receptors, and some growth factor genes. Estimates suggest that somewhere between 0.5% and 15% of genes on non-sex chromosomes exhibit random monoallelic expression, depending on the cell type. In human brain-derived stem cells, roughly 2% of assessed genes were monoallelically expressed. In immune-derived cell lines, about 2.2% of nearly 4,000 assessable genes showed clear monoallelic expression, with another 7.3% showing evidence based on limited data.
When Allelic Exclusion Fails
Failures in allelic exclusion are rare but consequential, particularly in the immune system. When a B cell expresses two different antibodies or a T cell carries two functional receptors, the screening mechanisms that normally eliminate self-reactive cells become unreliable. A cell might pass inspection because its dominant receptor looks safe, while its second receptor quietly targets a normal body protein.
The autoimmune diabetes model in mice illustrates this clearly. T cells that expressed low levels of a pancreas-targeting receptor alongside a dominant, harmless receptor were not deleted during development. But once those cells encountered the target protein in pancreatic tissue, the low-level receptor was enough to trigger an immune attack, destroying insulin-producing cells. The key insight is that even low expression of a self-reactive receptor, diluted by competition with a second receptor, can cause disease if the target antigen is concentrated in a specific organ.
This helps explain why allelic exclusion is so strongly conserved across species. It is not just an elegant feature of gene regulation. It is a safety mechanism that keeps the immune system from turning on the body it is supposed to protect.